TPH2 and breast cancer: The involvement of TPH2 as a putative breast cancer susceptibility locus is plausible, as the enzyme is exclusively expressed in neuronal cells of the central nervous system where it catalyzes the rate limiting step in serotonin (5-HT) biosynthesis, the chemical precursor of melatonin [31].